Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Valcyte contains the active ingredient valganciclovir. It is a prescription antiviral medication used to treat or prevent certain infections caused by cytomegalovirus (CMV).
Valcyte is used to treat CMV retinitis in adults with acquired immunodeficiency syndrome (AIDS).
CMV retinitis is a serious infection that affects the retina at the back of the eye. Without treatment, it can damage vision and may lead to blindness.
Valcyte helps control the infection and reduce the risk of further damage.
Valcyte may also be used to help prevent CMV disease after certain organ transplants.
People who receive an organ transplant usually take medicines that suppress the immune system. This can make it easier for CMV to become active and cause infection.
Valcyte may be prescribed when the transplant recipient is at increased risk of developing CMV disease.
Valcyte belongs to a group of medications called antivirals.
After you take Valcyte, the body converts valganciclovir into ganciclovir.
Ganciclovir blocks an enzyme the virus needs to make new viral DNA. This slows or stops CMV from multiplying and helps the immune system control the infection.
Valcyte helps control or prevent CMV, but it does not completely remove the virus from the body.
Take Valcyte exactly as prescribed and continue treatment for as long as your healthcare provider recommends.
Valcyte tablets are taken by mouth with food.
Taking Valcyte with food helps your body absorb the medication properly.
Swallow Valcyte tablets whole.
Do not crush, break, or chew the tablets.
Avoid touching broken or crushed tablets with your skin or eyes. If contact occurs, wash the affected skin well with soap and water. If the medication gets into your eyes, rinse them thoroughly with water.
For adults with normal kidney function who are being treated for active CMV retinitis, the usual starting dose is:
900 mg twice daily for 21 days.
After the initial treatment period, the usual maintenance dose is:
900 mg once daily.
The dose used to prevent CMV disease after an organ transplant is different from the dose used to treat CMV retinitis.
For adults with normal kidney function, the usual dose is 900 mg once daily.
The length of treatment depends on the type of transplant. For example, treatment may continue until 100 days after a heart or kidney-pancreas transplant, or until 200 days after a kidney transplant.
Valcyte is removed from the body mainly through the kidneys.
If your kidney function is reduced, your healthcare provider may lower your dose or have you take Valcyte less often.
Kidney function should be monitored during treatment so that your dose can be adjusted when necessary.
For certain children who receive a kidney or heart transplant, the Valcyte dose is calculated using factors such as:
The dose may need to be adjusted as the child grows or as kidney function changes.
Take Valcyte at about the same time or times every day.
If you take it twice daily, try to space the doses evenly, such as one dose in the morning and one in the evening.
Taking Valcyte regularly helps maintain a consistent amount of medication in your body.
Take Valcyte exactly as prescribed.
Do not skip doses, reduce your dose, or stop treatment without speaking with your healthcare provider.
Not taking enough Valcyte may allow CMV to become more active or may make treatment less effective.
If you miss a dose of Valcyte, take it as soon as you remember unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular schedule.
Do not take two doses at the same time to make up for a missed dose.
Valcyte (valganciclovir) is available in the following forms and strength:
Valcyte can cause serious decreases in blood cells.
These may include:
Your healthcare provider will usually order regular blood tests to monitor your blood cell counts during treatment.
Contact your healthcare provider if you develop unusual tiredness, shortness of breath, frequent infections, fever, unusual bruising, or bleeding.
Valcyte can cause or worsen kidney problems.
The risk may be higher if you:
Your healthcare provider may monitor your kidney function and adjust your Valcyte dose if needed.
Drink enough fluids unless your healthcare provider has told you to limit your fluid intake.
Valcyte may harm an unborn baby.
Females who can become pregnant should use effective birth control while taking Valcyte and for at least 30 days after the last dose.
Males with female partners who can become pregnant should use condoms during treatment and for at least 90 days after the last dose.
Tell your healthcare provider immediately if you or your partner becomes pregnant during treatment.
Valcyte may affect fertility in both males and females.
In males, it may temporarily or permanently reduce sperm production.
In females, it may reduce fertility.
Talk with your healthcare provider if you are concerned about future fertility before starting treatment.
Based on animal studies, valganciclovir has the potential to cause genetic damage and may increase the risk of cancer.
Your healthcare provider will weigh these potential risks against the benefits of treating or preventing CMV infection.
Valcyte may cause nervous system side effects such as:
Avoid driving, operating machinery, or doing other activities that require full alertness until you know how Valcyte affects you.
Contact your healthcare provider promptly if you develop severe confusion, unusual shaking, or a seizure.
Valcyte can cause digestive side effects such as nausea, vomiting, diarrhea, and abdominal discomfort.
Contact your healthcare provider if these symptoms are severe or persistent, especially if they make it difficult to stay hydrated.
Valcyte can interact with other medications, especially drugs that:
Tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, supplements, and herbal products you use.
Your healthcare provider may need to adjust your medications or monitor you more closely.
Serious allergic reactions are possible.
Seek emergency medical attention if you develop:
Valcyte requires regular monitoring.
Your healthcare provider may check:
Keep all scheduled blood tests and follow-up appointments while taking Valcyte.
Valcyte should be taken with food. Food helps your body absorb valganciclovir properly, so taking it with a meal can help the medication work as intended. Try to take Valcyte at about the same time each day.
The length of treatment depends on why you are taking Valcyte. For adults with active CMV retinitis, the usual starting treatment is 900 mg twice daily for 21 days. After this initial treatment, the dose is usually reduced to 900 mg once daily for maintenance. People taking Valcyte to prevent CMV after an organ transplant may need treatment for a different length of time. Take Valcyte for exactly as long as your healthcare provider recommends. Do not continue the higher twice-daily dose longer than prescribed.
Do not stop taking Valcyte without speaking with your healthcare provider. Valcyte helps control CMV, but it does not completely remove the virus from your body. Stopping treatment too early may allow CMV to become active again or cause the infection to worsen. Take Valcyte exactly as prescribed, even if you are feeling better.
Valcyte can be an effective treatment or preventive medication for CMV, but it can also cause serious side effects. One of the most important risks is bone marrow suppression, which can lower your white blood cells, red blood cells, and platelets. Very low blood cell counts can increase the risk of serious infections, anemia, or bleeding. Your healthcare provider will usually order regular blood tests during treatment to monitor your blood cell counts and kidney function. The dose may be changed or treatment may be stopped if serious side effects occur. Seek medical attention if you develop unusual bleeding or bruising, severe tiredness, shortness of breath, fever, or signs of infection.
| Generic name: | Valganciclovir |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 450mg |
| Quantities Available: | 60 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Valcyte (valganciclovir) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Valcyte is commonly prescribed in dosages of 450 mg, taken twice daily. For a 90-day supply, this means you would order 180 tablets (90 days x 2 tablets per day).
Yes, we sell valganciclovir on our website. You can enjoy low prices when you order through us. To purchase valganciclovir, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You have the option to submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Valcyte (valganciclovir) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Valcyte (Valganciclovir). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Valcyte (Valganciclovir).
REVIEWS